{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:00:17Z","timestamp":1780520417190,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jim.2013.04.012","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T09:01:36Z","timestamp":1367226096000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["ELISA for determination of total coagulation factor XII concentration in human plasma"],"prefix":"10.1016","volume":"394","author":[{"given":"Daniel Elenius","family":"Madsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Jakobsen","family":"Sidelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Brodersen","family":"Gram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2013.04.012_bb0005","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1172\/JCI113650","article-title":"A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein","volume":"82","author":"Agostini","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2013.04.012_bb0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/clinchem\/40.7.1233","article-title":"Limit of detection (LQD)\/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC\u2013MS assays of abused drugs","volume":"40","author":"Armbruster","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jim.2013.04.012_bb0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/hmg\/ddp517","article-title":"Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels","volume":"19","author":"Calafell","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jim.2013.04.012_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2141.1997.3513165.x","article-title":"Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage","volume":"99","author":"Citarella","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jim.2013.04.012_bb0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1084\/jem.138.6.1564","article-title":"Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein","volume":"138","author":"Cochrane","year":"1973","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2013.04.012_bb0030","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1016\/S0021-9258(17)38776-8","article-title":"Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa","volume":"260","author":"Cool","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2013.04.012_bb0035","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00001721-199607000-00004","article-title":"Measurement of activated factor XII in health and disease","volume":"7","author":"Coppola","year":"1996","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jim.2013.04.012_bb0040","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.04.012_bb0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2007.02530.x","article-title":"Evidence of a U-shaped association between factor XII activity and overall survival","volume":"5","author":"Endler","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jim.2013.04.012_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0161-5890(78)90070-6","article-title":"Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose","volume":"15","author":"Ey","year":"1978","journal-title":"Immunochemistry"},{"key":"10.1016\/j.jim.2013.04.012_bb0055","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/endo.136.11.7588244","article-title":"Molecular basis of estrogen regulation of Hageman factor XII gene expression","volume":"136","author":"Farsetti","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.jim.2013.04.012_bb0060","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1046\/j.1523-1755.2001.00009.x","article-title":"Role of contact system activation in hemodialyzer-induced thrombogenicity","volume":"60","author":"Frank","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.jim.2013.04.012_bb0065","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1016\/S0021-9258(17)44364-X","article-title":"Amino acid sequence of human beta-factor XIIa","volume":"258","author":"Fujikawa","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jim.2013.04.012_bb0070","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/ATVBAHA.107.155952","article-title":"Intrinsic pathway of coagulation and arterial thrombosis","volume":"27","author":"Gailani","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jim.2013.04.012_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(81)73054-4","article-title":"Preparation of monoclonal antibodies: strategies and procedures","volume":"73","author":"Galfr\u00e8","year":"1981","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jim.2013.04.012_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/B:THRO.0000037670.42776.cd","article-title":"The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature","volume":"17","author":"Girolami","year":"2004","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jim.2013.04.012_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/107602960501100105","article-title":"Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: no apparent causative relation","volume":"11","author":"Girolami","year":"2005","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.jim.2013.04.012_bb0090","first-page":"43","article-title":"Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction","volume":"143","author":"Halbmayer","year":"1993","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.jim.2013.04.012_bb0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1365-2141.2000.02251.x","article-title":"Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII","volume":"110","author":"Jones","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jim.2013.04.012_bb0100","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2013.04.012_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.jim.2013.04.012_bb0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2141.1994.tb04937.x","article-title":"John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia study","volume":"87","author":"Koster","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jim.2013.04.012_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647467","article-title":"Thromboembolism and bleeding tendency in congenital factor XII deficiency\u2014a study on 74 subjects from 14 Swiss families","volume":"65","author":"Lammle","year":"1991","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jim.2013.04.012_bb0120","series-title":"NCCLS Document EP5-A2","isbn-type":"print","article-title":"Evaluation of precision performance of quantitative measurement methods; approved guideline","author":"NCCLS","year":"2004","ISBN":"https:\/\/id.crossref.org\/isbn\/1562385429"},{"key":"10.1016\/j.jim.2013.04.012_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-7439(93)80008-6","article-title":"Calibration and assay development using the four-parameter logistic model","volume":"20","author":"O'Connell","year":"1993","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.jim.2013.04.012_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jim.2012.01.002","article-title":"A new enzyme-linked immunosorbent assay recognizing both rat and human activated coagulation factor XII (FXIIa)","volume":"376","author":"Papageorgiou","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2013.04.012_bb0135","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/JCM.32.10.2441-2447.1994","article-title":"Determination of parallelism and nonparallelism in bioassay dilution curves","volume":"32","author":"Plikaytis","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2013.04.012_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.mbc.0000178827.52242.89","article-title":"Clotting time analysis of citrated blood samples is strongly affected by the tube used for blood sampling","volume":"16","author":"Ramstrom","year":"2005","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jim.2013.04.012_bb0145","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI103109","article-title":"A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma","volume":"34","author":"Ratnoff","year":"1955","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2013.04.012_bb0150","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1182\/blood.V86.11.4134.bloodjournal86114134","article-title":"Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein","volume":"86","author":"Ravon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.04.012_bb0155","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In vivo roles of factor XII","volume":"120","author":"Renne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.04.012_bb0160","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","article-title":"Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding","volume":"118","author":"Revenko","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jim.2013.04.012_bb0165","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1160\/TH10-03-0171","article-title":"Factor XII: new life for an old protein","volume":"104","author":"Schmaier","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jim.2013.04.012_bb0170","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bcp.2007.10.003","article-title":"Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation","volume":"75","author":"Schousboe","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jim.2013.04.012_bb0175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2000-13216","article-title":"Fibrin clot formation and lysis: basic mechanisms","volume":"26","author":"Sidelmann","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.jim.2013.04.012_bb0180","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1055\/s-0037-1614368","article-title":"Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency\u2014a study on 73 subjects from 14 Swiss families","volume":"82","author":"Zeerleder","year":"1999","journal-title":"Thromb. Haemost."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175913001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175913001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T23:27:54Z","timestamp":1644881274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175913001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0022175913001476"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2013.04.012","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ELISA for determination of total coagulation factor XII concentration in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2013.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}